We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RC
376
Ready Capital
RC
$265M
$831K 0.1%
108,857
+21,909
+25% +$186K
REX icon
377
REX American Resources
REX
$1.44B
$830K 0.1%
35,876
-34,246
-49% -$780K
PRMW
378
DELISTED
Primo Water Corporation
PRMW
$830K 0.1%
+32,864
New +$734K
CRUS icon
379
Cirrus Logic
CRUS
$6.87B
$830K 0.1%
+6,679
New +$884K
USPH icon
380
US Physical Therapy
USPH
$1.17B
$828K 0.1%
+9,779
New +$868K
CVGW
381
DELISTED
Calavo Growers
CVGW
$820K 0.1%
+28,734
New +$702K
COF icon
382
Capital One
COF
$127B
$819K 0.1%
+5,472
New +$779K
AEIS icon
383
Advanced Energy
AEIS
$11.7B
$816K 0.1%
+7,757
New +$814K
EYE icon
384
National Vision
EYE
$1.66B
$816K 0.1%
+74,748
New +$872K
SRAD icon
385
Sportradar
SRAD
$4.34B
$815K 0.1%
67,284
+25,190
+60% +$288K
DOC icon
386
Healthpeak Properties
DOC
$15.5B
$812K 0.1%
35,515
-63,474
-64% -$1.37M
ACA icon
387
Arcosa
ACA
$7.14B
$810K 0.1%
8,546
-12,895
-60% -$1.13M
SBAC icon
388
SBA Communications
SBAC
$18.3B
$802K 0.1%
3,332
+1,158
+53% +$257K
COMP icon
389
Compass
COMP
$8.82B
$801K 0.1%
+131,051
New +$645K
ASTS icon
390
AST SpaceMobile
ASTS
$17.4B
$800K 0.1%
+30,609
New +$690K
NTB icon
391
Bank of N.T. Butterfield & Son
NTB
$2.4B
$799K 0.1%
21,659
+9,405
+77% +$348K
KFY icon
392
Korn Ferry
KFY
$4.13B
$794K 0.1%
10,559
-25,907
-71% -$1.82M
SCSC icon
393
Scansource
SCSC
$1.13B
$794K 0.09%
16,524
+11,591
+235% +$549K
HVT icon
394
Haverty Furniture Companies
HVT
$406M
$793K 0.09%
+28,881
New +$776K
EW icon
395
Edwards Lifesciences
EW
$47.8B
$787K 0.09%
+11,927
New +$867K
SNAP icon
396
Snap
SNAP
$7.6B
$786K 0.09%
+73,450
New +$838K
ATO icon
397
Atmos Energy
ATO
$29.7B
$785K 0.09%
5,661
+2,728
+93% +$350K
TAP icon
398
Molson Coors Class B
TAP
$7.71B
$781K 0.09%
+13,576
New +$726K
KROS icon
399
Keros Therapeutics
KROS
$202M
$780K 0.09%
13,439
+5,185
+63% +$256K
PCTY icon
400
Paylocity
PCTY
$6.97B
$779K 0.09%
+4,725
New +$719K
14 15
16
17 18

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.